NorthStar Medical Radioisotopes moved one step closer to producing molybdenum-99 Friday after winning three patents and one trademark approval from the U.S. Patent and Trademark Office.
NorthStar plans to produce the medical isotope, used for imaging procedures…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.



